OFFICIAL PUBLICATION OF

by its subsidiary APPco

The COVID impact

Guest Author 11/07/2021

How has COVID affected pharmacy valuations? John Thornett gives his three key learnings to date from 2021 valuations You see there is this thing called COVID. You may have heard about it (I say this with most of Australia currently in lockdown.) In the world of valuations, it provided just another challenge amongst a whole

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

The COVID impact

Previous Uncertainty over immunisation reporting

Next Vax approval as pharmacies contend with multiple cases

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Uncertainty over immunisation reporting

Next Vax approval as pharmacies contend with multiple cases

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.